IMRX

Conviction 24HealthcareScan · Mon, Aug 10, 2026

IMRX$4.53+0.44%

ResistanceSupportVol 14

Vol MA14 1.02M

May 11May 28Jun 16Jul 6Jul 23Aug 10

Immuneering CorpPHARMACEUTICAL PREPARATIONSwww.immuneering.com ↗

Price4.53

Change+0.44%

Gap+0.00%

Rel volume9.16×

Avg volume1M

Avg $ vol4.51M

SMA 204.46

SMA 504.58

SMA 2005.38

Price vs 50-1.04%

Price vs 200-15.88%

MA stackbearish

50/200 cross—

Supertrenddown · 4.92

RSI (14)50

MACD hist0.03

MACD crossbull · 2d

Stoch %K / %D72 / 64

ADX (14)20

+DI / −DI23 / 19

RSI divergence—

MACD divergence—

ATR %+5.50%

ADR %5.22%

52w high9.26

52w low3.04

From 52w high-51.08%

Above 52w low+49.01%

New 52w highNo

SqueezeOff

Bollinger width26.34%

%B0.56

Donchian pos41.15%

Donchian high5.25

Donchian low4.03

AVWAP (52w high)5.81

vs AVWAP high-22.06%

AVWAP (52w low)5.82

vs AVWAP low-22.19%

OBV trendUp

Chaikin MF (20)-0.36

Today vs 20d9.16×

Avg vol (14d)1.02M

Avg vol (20d)1M

Avg $ vol (20d)4.51M

Market cap—

RS 3m (vs SPY)-19.30%

RS 6m (vs SPY)-14.34%

RS line new highNo

Trend template1/8

Technical rank24.1

1 week+8.63%

1 month-11.35%

3 months-13.22%

6 months-8.11%

1 year+29.06%

YTD-31.57%

P/E-2.09

P/B0.61

P/S—

P/FCF-2.58

EPS-1.27

Div yield—

ROE-29.37%

ROA-27.73%

Debt/Eq—

Current19.47

EV/EBITDA-1.29

Gross margin—

Net margin—

Rev growth-100.00%

EPS growth8.21%

Price target—

Target upside—

Analyst rating—

Institutional—

Ent. value75.92M

Revenue0

Net income-17.27M

Gross profit0

Free cash flow-45.49M

IndustryPHARMACEUTICAL PREPARATIONS

ExchangeNasdaq

Shares out64.7M

Employees55

ListedFri, Jul 30, 2021

Free float—

Float %—

Short interest—

Days to cover—

Short volume—

Squeeze score—

Next earnings—

EPS forecast—

Last EPS vs est—

Last surprise—

Setup gradeD

Conviction24 / 100

Pattern quality—

Tech rank24.1 / 100

Group rank86 / 100 · Leading

Status laneNo active setup

Setup direction—

Pattern family

Resistance5.21

Support4.15

Days since event—

Candle confirm—

News sentiment—

Financials as of Tue, Jun 30, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in IMRX

All disclosures →

No recent disclosed trades by Congress in IMRX. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in IMRX · 1 buy

Insider	Side	Shares	Value	Traded	Filed
Gengos Andrew Chief Financial Officer · Stock Option · 2026-07-16	Grant	650K	—	2026-07-16	2026-07-17

SEC filings

EDGAR filings in IMRX · 6 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.